Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Wittekind

Showing results (101-110 of 127) with videos related to

Pageof 13
Sort By:
International Journal of Radiation Oncology, Biology, Physics|January 2, 2007
Rectal cancer delivery of radiotherapy in adequate time and with adequate dose is influenced by treatment center, treatment schedule, and gender and is prognostic parameter for local control: results of study CAO/ARO/AIO-94Rainer Fietkau, Claus Rödel, Werner Hohenberger, et al.
Journal of the National Cancer Institute|December 6, 2017
Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal CancerEmmanouil Fokas, Philipp Ströbel, Rainer Fietkau, et al.
International Journal of Colorectal Disease|June 7, 2005
TNP-470 fails to block the onset of angiogenesis and early tumor establishment in an intravital minimal disease modelGrigore Cernaianu, Sibylle Frank, Katrin Erbstösser, et al.
Plos One|March 19, 2014
Non-invasive assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopyThomas Karlas, David Petroff, Nikita Garnov, et al.
Oncotarget|August 16, 2019
Tumor-associated macrophages and individual chemo-susceptibility are influenced by iron chelation in human slice cultures of gastric cancerSebastian Prill, Jakob Rebstock, Anja Tennemann, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 18, 2013
Gender affects acute organ toxicity during radiochemotherapy for rectal cancer: long-term results of the German CAO/ARO/AIO-94 phase III trialHendrik Andreas Wolff, Lena-Christin Conradi, Tim Beissbarth, et al.
Gastroenterology|January 24, 2012
Autoimmunity, intestinal lymphoid hyperplasia, and defects in mucosal B-cell homeostasis in patients with PTEN hamartoma tumor syndromeMario Heindl, Norman Händel, Joanne Ngeow, et al.
Cancer Medicine|April 14, 2016
Organotypic slice cultures of human gastric and esophagogastric junction cancerJustus Koerfer, Sonja Kallendrusch, Felicitas Merz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2008
Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study GroupPeter Albers, Roswitha Siener, Susanne Krege, et al.
Clinical Colorectal Cancer|December 14, 2017
Individual Susceptibility Analysis Using Patient-derived Slice Cultures of Colorectal CarcinomaRasmus Sönnichsen, Laura Hennig, Vera Blaschke, et al.
Pageof 13

Showing results (101-110 of 127) with videos related to

Sort By:
Pageof 13
International Journal of Radiation Oncology, Biology, Physics|January 2, 2007
Rectal cancer delivery of radiotherapy in adequate time and with adequate dose is influenced by treatment center, treatment schedule, and gender and is prognostic parameter for local control: results of study CAO/ARO/AIO-94Rainer Fietkau, Claus Rödel, Werner Hohenberger, et al.
Journal of the National Cancer Institute|December 6, 2017
Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal CancerEmmanouil Fokas, Philipp Ströbel, Rainer Fietkau, et al.
International Journal of Colorectal Disease|June 7, 2005
TNP-470 fails to block the onset of angiogenesis and early tumor establishment in an intravital minimal disease modelGrigore Cernaianu, Sibylle Frank, Katrin Erbstösser, et al.
Plos One|March 19, 2014
Non-invasive assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopyThomas Karlas, David Petroff, Nikita Garnov, et al.
Oncotarget|August 16, 2019
Tumor-associated macrophages and individual chemo-susceptibility are influenced by iron chelation in human slice cultures of gastric cancerSebastian Prill, Jakob Rebstock, Anja Tennemann, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 18, 2013
Gender affects acute organ toxicity during radiochemotherapy for rectal cancer: long-term results of the German CAO/ARO/AIO-94 phase III trialHendrik Andreas Wolff, Lena-Christin Conradi, Tim Beissbarth, et al.
Gastroenterology|January 24, 2012
Autoimmunity, intestinal lymphoid hyperplasia, and defects in mucosal B-cell homeostasis in patients with PTEN hamartoma tumor syndromeMario Heindl, Norman Händel, Joanne Ngeow, et al.
Cancer Medicine|April 14, 2016
Organotypic slice cultures of human gastric and esophagogastric junction cancerJustus Koerfer, Sonja Kallendrusch, Felicitas Merz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2008
Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study GroupPeter Albers, Roswitha Siener, Susanne Krege, et al.
Clinical Colorectal Cancer|December 14, 2017
Individual Susceptibility Analysis Using Patient-derived Slice Cultures of Colorectal CarcinomaRasmus Sönnichsen, Laura Hennig, Vera Blaschke, et al.
Pageof 13